Aeluma Inc is a semiconductor company specializing in sensors and communications... Show more
Aeluma, Inc., a developer of optoelectronic semiconductors for sensing, communication, and computing, faces a pivotal Q3 Fiscal 2026 earnings report. Amid a booming semiconductor sector driven by AI and data center demands, this release will gauge the company's traction in commercializing its scalable photonic technologies. Recent quarters showed revenue stability around $1.3-1.4 million from R&D contracts, a sharp rise from prior fiscal year levels. With FY2025 revenue under $3 million and FY2026 guidance at $4-6 million, Q3 progress is crucial for validating growth trajectory and investor confidence in long-term profitability. Missing expectations could pressure the stock, currently trading near $17, while beats may fuel upside in this high-growth niche.
Wall Street anticipates Q3 Fiscal 2026 revenue of $1.43 million, building on Q2's $1.3 million and Q1's $1.4 million, primarily from government and commercial R&D contracts. Consensus EPS is pegged at -$0.06, reflecting ongoing investments in fabrication and product development amid pre-revenue commercialization phases.
Aeluma has consistently reaffirmed its full-year revenue outlook of $4-6 million, implying Q3 and Q4 must deliver to meet the midpoint of $5 million. Key metrics to watch include gross margins, R&D spend (gross margin N/A pre-scale), cash burn, and updates on customer wins in lidar, datacom, and quantum sensing. Historically, the stock reacted positively to Q2's EPS beat despite a slight revenue shortfall, rising post-release, underscoring focus on per-share execution.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to uncover potential plays in the semiconductor space.
Heading into Q3 earnings, expected around early May, sentiment is cautiously optimistic. Aeluma's cash reserves and reaffirmed guidance bolster confidence, with shares up over 150% in the past year amid sector tailwinds. Risks include revenue variability from contract timing and competition in photonics. Past reactions show volatility: Q2 EPS beat drove gains despite revenue dip, while guidance adherence remains a sentiment driver. Options activity and short interest are low, suggesting limited downside pressure pre-report.
Post-Q3, investors should track adherence to FY2026 revenue guidance of $4-6 million. With half-year revenue near $2.7 million, the back half needs acceleration through new contracts and early commercial sales in datacom and sensing applications.
Cash management is a strength, with $38.6 million at Q2 end supporting R&D without dilution risks. Monitor burn rate and updates on fab capacity scaling, critical for gross margins as revenues grow.
Industry dynamics favor Aeluma: rising demand for efficient photonics in AI accelerators, lidar for autonomy, and quantum tech. Upcoming catalysts include potential customer announcements and FY2027 outlook. Broader semi cycles, supply chain stability, and M&A (mergers and acquisitions) activity in optoelectronics will also influence trajectory. Balanced execution here could position Aeluma for inflection toward profitability.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.